Leon Herndon Jr, MD, a glaucoma specialist, ophthalmologist, and professor of ophthalmology at the Duke University Eye Center, explains certain considerations ophthalmologists may need to take into account when treating older patients and the need for more specialists to meet clinical demand.
A concern is that over time, there may not be enough ophthalmologists to treat the growing rates of patients with glaucoma, said Leon Herndon Jr, MD, a glaucoma specialist, ophthalmologist, and professor of ophthalmology at the Duke University Eye Center.
Transcript:
Should primary open-angle glaucoma have an age-specific approach to treatment? If so, what can ophthalmologists do to better tailor care for a patient, based on their age?
We know that as patients get older, they'll have more trouble with complying with therapy; [with] arthritis, cognitive decline as we get older, [we] have to rely more on caregivers to give patients their drops. Some of the medications may have systemic side effects. Alpha-agonists may impact older patients' ability to be active, and topical beta-blocker therapy may also play a role systemically in older patient populations. So we do need to be a little more selective with our treatment options for the elderly. Laser options may be more reasonable for an older population that you might not want to subject to incisional surgery. I would say that yes, we do need to really factor the patient's age into our decision-making when it comes to their treatment options.
What challenges does the ophthalmology field face as more and more Americans continue to live longer?
As the patient population continues to age, we're going to see more and more glaucoma. And my concern is that over time, we may have fewer and fewer ophthalmologists who are available to meet this manpower demand. So we do need to make efforts to train the next generation of those who will take care of glaucoma patients and pay attention to their patients’ needs when it comes to their home environment, as well as their cognitive and physical abilities.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More